Although a significant difference between the two groups was not obtained, there was a trend in shorter survival times in mice bearing SMARCD3 + MYCS62D-induced tumours compared with MYCS62D-induced tumours (Extended Data Fig. 3f). Here, SMARCD3 is linked to neoplasm.